RSV vaccine targets the respiratory syncytial virus, a frequent contributor to respiratory infections, especially affecting infants and older individuals.
FDA Approved RSV Vaccines
The FDA has approved RSV vaccines to protect adults and infants against highly contagious diseases.
Vaccines Against Respiratory Syncytial Virus
RSV is a respiratory syncytial virus that causes lower respiratory tract infections in newborns, elderly people, and immunocompromised patients.
